A practical guide for providers: how to help patients find Buspar (Buspirone) when pharmacies are out of stock, including workflow tips and alternative strategies.
You write a Buspirone prescription and your patient calls the next day — the pharmacy says they don't have it. It's a scenario that plays out regularly in primary care and psychiatry practices, even when there's no national shortage.
While Buspirone supply is generally stable in 2026, localized stock gaps at chain pharmacies remain common enough that every prescriber should have a game plan. This guide covers what's happening with Buspirone availability, why patients struggle to fill prescriptions, and concrete steps you can take to help.
Buspirone is not on the FDA's drug shortage list as of early 2026. The significant shortage of 2019-2020 — triggered by manufacturer exits and compounded by pandemic-era demand — has resolved. Multiple generic manufacturers (Teva, Aurobindo, Par Pharmaceutical, and others) are actively producing all five tablet strengths: 5 mg, 7.5 mg, 10 mg, 15 mg, and 30 mg.
However, "not in shortage" at the national level doesn't always match the patient experience at their local CVS or Walgreens. Here's why.
Large chain pharmacies use automated ordering systems that predict demand based on historical dispensing patterns. If a store hasn't filled many Buspirone prescriptions recently, its stock level will be low. A single new patient or a prescriber in the area writing more Buspirone can create a temporary gap.
Not all strengths are equally stocked. The 5 mg and 10 mg tablets are the most commonly dispensed and therefore the most consistently available. Higher strengths — particularly 15 mg and 30 mg — may have thinner stock at individual locations.
When supply is tight for any generic, wholesalers may allocate inventory based on pharmacy purchasing history. A pharmacy that hasn't ordered Buspirone recently may receive a lower allocation than one that orders regularly.
Many patients wait until they're completely out of medication before trying to fill a prescription. By that point, a brief stock gap becomes an urgent problem.
When writing Buspirone prescriptions, consider that the most commonly stocked strengths are 5 mg and 10 mg. If clinically appropriate, prescribing in these strengths (even if it means more tablets per dose) can improve fill rates.
For example, instead of writing for 15 mg tablets (less consistently stocked), consider 10 mg + 5 mg, or three 5 mg tablets. The total daily dose remains the same, but the pharmacy is more likely to have it on hand.
Medfinder provides real-time pharmacy stock checking for Buspirone and hundreds of other medications. You can recommend it to patients who are having trouble finding their medication, or your staff can check it on the patient's behalf during the visit.
Having your front desk or care coordinators bookmark Medfinder can save significant time when patients call about stock issues.
Independent pharmacies often use different wholesale distributors than chain pharmacies and may have access to stock when the chains don't. They also tend to be more willing to:
If your practice doesn't already have relationships with 2-3 independent pharmacies in the area, it's worth establishing them.
Buspirone is not a controlled substance, making it eligible for mail-order in all states. This can be a reliable backup when local pharmacies are out of stock. Options include:
Mail-order is especially useful for stable patients on maintenance doses who don't need immediate fills.
For patients who consistently can't find Buspirone, or who need treatment while waiting for a fill, have a backup plan:
For a comprehensive comparison, see alternatives to Buspar.
When Buspirone isn't available and you need to consider other options, here's a quick reference:
When starting a patient on Buspirone, mention that occasional pharmacy stock issues can happen and provide actionable guidance upfront:
If your e-prescribing system allows it, route Buspirone prescriptions to pharmacies with reliable stock. Some EHR systems flag preferred pharmacies based on fill success rates.
Create a simple script for when patients call about unfilled prescriptions:
When patients report fill difficulties, document it in the chart. Patterns may emerge that inform prescribing strategy — for example, if 30 mg tablets are consistently hard to find in your area, defaulting to 15 mg BID may be more practical.
Buspirone is available, affordable, and clinically effective — but pharmacy-level stock issues remain a real obstacle for some patients. A proactive approach that includes prescribing flexibility, real-time stock tools like Medfinder, and backup options keeps patients on track without unnecessary treatment disruptions.
For additional resources:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
